EVIDENCED BASED PRACTICE

tonny4u

ATTACHEDWK7ASSM..doc

Home >Nursing homework help >EVIDENCED BASED PRACTICE

[Type text] [Type text] [Type text]

PAGE

[Type text]

CRITICAL APPRAISAL OF RESEARCH

Research Critical Appraisal

Walden university

Course: NURS-6052. Essentials of Evidenced Based Practice

Research is one of the major contributors to professional development in most career fields, especially in the health care industry, since it helps healthcare providers adjust, inform, and monitor specific ways of providing care. The possibility to analyze research evidence properly is important to avoid assuming that all the carried out research are of equal quality and rationality. This paper critically analyzes some of the best practices that emerge in the research article: 'Phillips, J. L., Jaworska, N., Kamler, E., Bhat, V., Blier, J., Foster, J. A., ... & Moazamigoudarzi, Z. (2020). A randomized, crossover comparison of ketamine and electroconvulsive therapy for the treatment of major depressive episodes: a Canadian biomarker integration network in depression (CAN-BIND) study protocol. BMC Psychiatry, 20, 1-11.’ Best practices represent high-quality care, which is focused on the most favorable convincing standards of care and directs the care providers on solutions or strategies to recognize a problem.

One of the best practices that the research brings out is the high-quality patient care provision and discharge during the study. In this research, the inclusion of participants into the study followed a well provided written informed consent prior to initiating the patients into the study or any procedures related to the study. The participants chosen for the study were inpatient and outpatients who were eligible for standard ECT, and they were willing to accept allocation to either ECT or IV ketamine arms. In the research to ensure that ECT and ketamine treatment was suitable for the eligible participants, they underwent a comprehensive medical workup that involves a medical history, vital signs measurements, physical examination, pregnancy screening, and recording associated medical jurisdiction. The researchers administered ECT according to the standards of care, selecting particular treatment variables through the psychiatrist's judgment, who was providing care. There has been established a data and safety surveilling team to check and maintain participants’ safety and treatment effectiveness in the process of the study. According to Mathew et al. (2019), this study assist individuals with major depression that is resistant to other antidepressant and the results of this research can also help the physicians to find a new treatment strategy.

Reference

Mathew, S. J., Wilkinson, S. T., Altinay, M., Asghar-Ali, A., Chang, L. C., Collins, K. A., ... & Malone, D. A. (2019). ELEctroconvulsive therapy (ECT) vs. Ketamine in patients with Treatment-resistant Depression: The ELEKT-D study protocol. Contemporary Clinical Trials, 77, 19-26.

Phillips, J. L., Jaworska, N., Kamler, E., Bhat, V., Blier, J., Foster, J. A., ... & Moazamigoudarzi, Z. (2020). A randomized, crossover comparison of ketamine and electroconvulsive therapy for the treatment of major depressive episodes: a Canadian biomarker integration network in depression (CAN-BIND) study protocol. BMC Psychiatry, 20, 1-11.

Evaluation Table

Research appraisal

APA formatted citation of the selected article.

Article #1

Article #2

Article #3

Article #4

Phillips, J. L., Jaworska, N., Kamler, E., Bhat, V., Blier, J., Foster, J. A., ... & Moazamigoudarzi, Z. (2020). A randomized, crossover comparison of ketamine and electroconvulsive therapy for the treatment of major depressive episodes: a Canadian biomarker integration network in depression (CAN-BIND) study protocol. BMC Psychiatry, 20, 1-11.

Enneking, V., Dzvonyar, F., Dück, K., Dohm, K., Grotegerd, D., Förster, K., ... & Goltermann, J. (2020). Brain functional effects of electroconvulsive therapy during emotional processing in major depressive disorder. Brain Stimulation.

Elias, A., Phutane, V. H., Clarke, S., & Prudic, J. (2018). Electroconvulsive therapy in the continuation and maintenance treatment of depression: Systematic review and meta-analyses. Australian & New Zealand Journal of Psychiatry, 52(5), 415-424.

Niazi, A., Theilmann, W., Brandt, C., Rantamäki, T., Matsui, N., Rhein, M., ... & Frieling, H. (2018). P11 promoter methylation predicts the antidepressant effect of electroconvulsive therapy. Translational psychiatry, 8(1), 1-13.

Evidence Level *

(I, II, or III)

III

III

II

III

Conceptual Framework

Describe the theoretical basis for the study (If there is no one mentioned in the article, say that here).

Present studies emphasize the efficacy of some potent antidepressant pharmacological interventions, including ketamine in reducing signs of common depressive incidents. This research explains the current multi-Centre, crossover, non-inferior trial, and More. It further explains which compares the acute treatment of people who have met a diagnostic basis for common depressive incidents using ketamine and ECT therapy on effectiveness, therapeutic impact, adverse effects as well as healthcare resource utilization.

When this researcher analyzed the evidence about the Major depressive disorder, one of the most effective treatment strategies discovered is the (ECT) electroconvulsive therapy. There is growing research on the brain structure changes as there is increased ECT, and the impact of ECT on brain operation when processing emotions is currently unknown.

Researchers have continuously not relented their efforts in finding the treatment of Major depressive disorder, among of which ECT therapy and maintaining ECT therapy has been researched to evaluate their effectiveness in averting deterioration and reoccurrence of depression.

Although ECT is one of the most functional treatment choices for crucial depressive disorder, some patients are still rebellious to the ECT. The study involves a translational approach to understand possible biomarkers to predict the response of ECT. However, in this literature, the research aims to Researchers have continuously not relented their efforts to find the treatment of Major depressive disorder, among which ECT therapy and maintaining them has been researched to evaluate their effectiveness in averting deterioration reoccurrence of depression.

This writer further identifies observations by the potential discoveries for ECT response through developing a rat design of pharmacoresistant depression then interpret the findings to a depressive patient in a clinical study.

Design/Method

Describe the design and how the study was carried out (In detail, including inclusion/exclusion criteria).

This writer elaborates on the study of the efficacy of Intravenous Ketamine infusion treatment compared with electroconvulsive therapy (ECT). Conduction of the research followed multi-centered, longitudinal, accidental crossover, and other equivalent trials.

This article research method involves a non-randomized longitudinal study where individuals with MDD are evaluated before and after ECT treatment. In this article, healthy controls are compared base on gender and age. Other methods used include magnetic resonance imaging acquired twice and the beginning and following six weeks through a conscious face-matching model.

In the article, the study's inclusions criteria involved randomized controlled exams, individuals older than 18 years with crucial depressive disorder, and response following severe ECT.

This article's research method is a comparison between continuous maintenance of ECT for individuals with or without antidepressant therapy and accurate intervention of subsequent ECT continuous single pharmacological antidepressant therapy. Research with ITT analysis was involved in lowering bias in the process of the study.

The study research method to measure depression symptoms on the rats was through the use of a battery behavioral test, and novelty-induced hypophagia to eliminate the bias of getting some effects of CMS.

The Wistar rats were chosen in this study since they portray high anxiety-related characteristics, and they respond highly to CMS compared to other rats.

In a clinical study from the 11 patients, the response was noted when one reduced >= 50% Montgomery Asberg Depression Scale.

Sample/Setting

The number and characteristics of

patients, attrition rate, etc.

The study involvedwith 240 participants who were recruited at four centers across Canada. Participants are directly recruited from the ECT services referral and waitlist for each participating hospital.

In this study, there are 37 patients suffering from MDD, and they were treated through ECT, as well as 37 health controls were applied in the current research. The participants were enrolled from the inpatient list from the psychiatry department of the university of muenster. All the patients were suffering from a recent acute depressive experience and achieved the standards of MDD.

The research involved 436 patients who were suffering from a major depressive disorder.

All the patients were individuals above the age of 18 years.

This article's research involves 46 male Wistar outbred rats that underwent the CMS protocol.

The Wistar outbred rats portray high anxiety behaviors and a high response to CMS compared to other types of rats.

The clinical experiment involved 11 in-patients who were experiencing pharmacoresistant depression.

Major Variables Studied

List and define dependent and independent variables.

The variable that has been studied here is the comparison between ECT therapies in treating crucial depressive episodes.

The research variable is to study ECT's functional brain effects when emotional processing in major depressive disorder.

This research tries to analyze the efficacy of continuous ECT therapy and maintenance ECT treatment on averting recurrence of depression compared to antidepressant pharmacotherapy.

This study tries to identify if biomarkers' prescreening can assist in recognizing patient eligibility for primary ECT therapy.

Measurement

Identify primary statistics used to answer clinical questions (You need to list the actual tests done).

Montgomery-Asberg depression rating scale was used to measure the depression rate among the patients.

ECT was carried out 3 times weekly by the use of Thymatron IV systems, where all the patients were required to have inpatient therapy for the entire period of the ECT series.

This study analyzes the effectiveness of continuous ECT treatment in eliminating the repetitive occurrence of depression compared to antidepressant pharmacotherapy.

The study uses different tests such as the battery of behavioral tests, and novelty-induced hypophagia, among other tests.

Data Analysis Statistical or

Qualitative findings

(You need to enter the actual numbers determined by the statistical tests or qualitative data).

The main outcome measure is the percentage of participants meeting antidepressant response criteria of less than or equal to 50% reduction in MADRS score of less than 22. The therapeutic impact speed is recognized as the amount of treatment needed for the participant to initially meet antidepressant response standards. The Kaplan-Meier survival analysis is applied to contrast the mean number of needed therapy for initial response to ECT and ketamine in the course of the randomized treatment stage. The side effects are analyzed by adding up the total frequency and seriousness score for the TSEs initiated following the last therapy in the process of randomized treatment.

In this research, the SPSS statistics are used to perform analysis on demographic, clinical, and behavioral data. To analyze ECT's impact on depression seriousness, a t-test was carried out to compare the HDRS rating baseline with the HDRS score following ECT in the MDD category. The evaluation of functional biomarkers involved in ECT response and the responder's pre-treatment brain operation and the non-responder categories was contrasted through a self-sufficient t-test.

The main data analysis used in this study is based on the patients' division into groups of those who experienced a weakening in the process of the study and measured the threat ratio to analyze the distinction between ineffective therapy among the groups.

The study information was pooled based on the weighted average, and heterogeneity was assessed using the p values.

The research analysis suggests that when the depression severity was evaluated weekly in the process of ECT treatment. When the Hamilton Depression Scale rating reduced by >= 50% in the process of treatment, it was regarded as a response to therapy.

Findings and Recommendations

General findings and recommendations of the research

This article's findings explain that there is a demand to enhance therapy results among people with mood disease, and they do not respond to other treatment methods. Although ECT remains among the most productive intervention for treatment-resistance MDEs, it is still not properly utilized.

The article's findings suggest that ECT is effective since HDRS outcomes were reduced greatly in the MDD category from pre-to post-therapy.

The research shows that there is an elevation in ACC processes in individuals suffering from MDD following ECT when processing emotional things of adverse feelings.

The pooled data's research analysis suggested that continuous ECT treatment and maintaining ECT therapy with pharmacotherapy brought about significantly less relapse and recurrence than pharmacotherapy alone.

The CMS depression model is a highly trusted means of reflecting on the symptoms of people's MDD on rats to assess antidepressant therapy effects.

Appraisal and Study Quality

The worth of the research practice

Elaborations of the :

Strengths and limitations of the research .

Risks associated with the implementation of the suggested practices or processes detailed in the research.

Feasibility of use in your practice.

This article's research is objected to compare the effectiveness, speed of therapy effectiveness, the side effects as well as healthcare resources utilization involved in ketamine and ECT through a spontaneous and crossover design with properly communicated clinical results.

One of the article's strengths is that it recognizes biomarkers of response to ECT or ketamine, which lowers delay in clinical improvement and improves remission rates.

These articles research contributing to explaining the mechanism of the antidepressant impact of ketamine and ECT and recognizing predictors of therapy results.

The research aims at investigating the functional transformation of ECT and biomarkers involved in therapy response when deliberately emotional processing.

The results of the article bring out a better comprehension of possible ECT impacts on emotional processing.

The strength of this article's research is that it comprises a large number of participants who were receiving ECT therapy and analysis of impact on brain operation corresponds with conscious emotion processing in a future strategy through paradigm-based fMRI.

One of the strengths of this study is its huge number of participants who were receiving ECT treatment.

One of the limitations of the research it has limited generalizability due to the age restriction.

One of the limitations of this study is that the researchers did not evaluate methylation or RNA in rats' surrounding circulation, and they also failed to evaluate RNA samples gathered from the patients due to technical issues.

The strength of this study is that the researchers were able to access lab rats as well as patients who were suffering from major depressive disorders.

Key findings

Ketamine and ECT are effective strategies to treat blood pressure. With the right monitoring, ketamine may, in the future, be applied as a less inconvenient, possibly more used, and cheaper choice compared to ECT in treatment-resistant individuals who experience MDE.

Following ECT, individuals with MDD showed a remarkable improvement in ACC processes when processing adverse emotional stimuli. This impact has driven some responders, while non-responders showed no increase.

The major finding of the research is that ECT and pharmacotherapy are very effective in reducing the risk of depression from reoccurring.

Patients who respond to ECT should be treated using ECT treatment after the disorder has been recognized, and those patients who do not respond to ECT should not receive ECT treatment since it will lead to increased stigmatization of this treatment option.

Outcomes

With proper checkup, ketamine is less inconvenient, possibly more tolerated, and a cheaper choice compared to ECT in critical depressed treatment resisting individuals who experience MDE.

The study outcome shows that ECT brings about an elevation in ACC activity when processing adverse emotions in patients experiencing critical depressive disorder.

The research outcome shows that continuous ECT is effective in preventing the recurrence of depression compared to antidepressant pharmacotherapy.

The research outcome shows that the promoter methylation does not change with time, but it revealed responders and non-responders since it was higher in responders than in non-responders prior to ECT.

General Notes/Comments**

The research can assist in providing understanding and progress in treating MDEs in unipolar MDD and BP.

This study provides a better comprehension of possible ECT impacts on emotional activities when focusing on ACC processes as the biomarker to therapy outcome.

This article's research shows that further study on ECT can be carried out to offer more understanding of its effect on depression.

This study tries to prove that biomarkers' prediction on the response of ECT will reduce costs and recognize patient eligibility for ECT treatment and assist in creating advanced ECT and new treatment methods for the depressed patient who resist presenting antidepressant treatments.

* These levels are from the Johns Hopkins Nursing Evidence-Based Practice: Evidence Level and Quality Guide

· Level I

Experimental, randomized controlled trial (RCT), systematic review RTCs with or without meta-analysis

· Level II

Quasi-experimental studies, a systematic review of a combination of RCTs and quasi-experimental studies, or quasi-experimental studies only, with or without meta-analysis

· Level III

Nonexperimental, a systematic review of RCTs, quasi-experimental with/without meta-analysis, a qualitative, qualitative systematic review with/without meta-synthesis

· Level IV

Respected authorities’ opinions, nationally recognized expert committee/consensus panel reports based on scientific evidence

· Level V

Literature reviews, quality improvement, program evaluation, financial evaluation, case reports, nationally recognized expert(s) opinion based on experiential evidence

**Note on Conceptual Framework

· Scholars generate hypothetical and theoretical contexts that incorporate a metaphysical and practical standard in order to help give purpose to their work. A proper philosophy stipulates circumstance for the conclusion of the events directed in the research. The data collection and analysis are also based on the theoretical and conceptual framework.

· Hypothetical and theoretical contexts deliver support of academic standards and procedures. The contexts in questions can also provides an justification of why the analysis is applicable and how the examiner anticipates to fill the gap in the literature.

· Literatures like peer reviewed Journals, Articles and other studies does not always clearly differentiates between a hypothetical or theoretical framework. With that being said, there are slight differences between the two.

References

The Johns Hopkins Hospital/Johns Hopkins University (n.d.). Johns Hopkins nursing evidence-based practice: Appendix C: evidence level and quality guide. Retrieved October 23, 2019, from https://www.hopkinsmedicine.org/evidence-based-practice/_docs/appendix_c_evidence_level_quality_guide.pdf

Grant, C., & Osanloo, A. (2014). Understanding, Selecting, and Integrating a Theoretical Framework in Dissertation Research: Creating the Blueprint for Your" House." Administrative Issues Journal: Education, Practice, and Research, 4(2), 12-26.

Walden University Academic Guides (n.d.). Conceptual & theoretical frameworks overview. Retrieved October 23, 2019, from https://academicguides.waldenu.edu/library/conceptualframework

Critical Appraisal Tool Worksheet Template

© 2018 Laureate Education Inc. 1

APA formatted citation of the selected article.	Article #1	Article #2	Article #3	Article #4
	Phillips, J. L., Jaworska, N., Kamler, E., Bhat, V., Blier, J., Foster, J. A., ... & Moazamigoudarzi, Z. (2020). A randomized, crossover comparison of ketamine and electroconvulsive therapy for the treatment of major depressive episodes: a Canadian biomarker integration network in depression (CAN-BIND) study protocol. BMC Psychiatry, 20, 1-11.	Enneking, V., Dzvonyar, F., Dück, K., Dohm, K., Grotegerd, D., Förster, K., ... & Goltermann, J. (2020). Brain functional effects of electroconvulsive therapy during emotional processing in major depressive disorder. Brain Stimulation.	Elias, A., Phutane, V. H., Clarke, S., & Prudic, J. (2018). Electroconvulsive therapy in the continuation and maintenance treatment of depression: Systematic review and meta-analyses. Australian & New Zealand Journal of Psychiatry, 52(5), 415-424.	Niazi, A., Theilmann, W., Brandt, C., Rantamäki, T., Matsui, N., Rhein, M., ... & Frieling, H. (2018). P11 promoter methylation predicts the antidepressant effect of electroconvulsive therapy. Translational psychiatry, 8(1), 1-13.
Evidence Level * (I, II, or III)	III	III	II	III
Conceptual Framework Describe the theoretical basis for the study (If there is no one mentioned in the article, say that here).**	Present studies emphasize the efficacy of some potent antidepressant pharmacological interventions, including ketamine in reducing signs of common depressive incidents. This research explains the current multi-Centre, crossover, non-inferior trial, and More. It further explains which compares the acute treatment of people who have met a diagnostic basis for common depressive incidents using ketamine and ECT therapy on effectiveness, therapeutic impact, adverse effects as well as healthcare resource utilization.	When this researcher analyzed the evidence about the Major depressive disorder, one of the most effective treatment strategies discovered is the (ECT) electroconvulsive therapy. There is growing research on the brain structure changes as there is increased ECT, and the impact of ECT on brain operation when processing emotions is currently unknown.	Researchers have continuously not relented their efforts in finding the treatment of Major depressive disorder, among of which ECT therapy and maintaining ECT therapy has been researched to evaluate their effectiveness in averting deterioration and reoccurrence of depression.	Although ECT is one of the most functional treatment choices for crucial depressive disorder, some patients are still rebellious to the ECT. The study involves a translational approach to understand possible biomarkers to predict the response of ECT. However, in this literature, the research aims to Researchers have continuously not relented their efforts to find the treatment of Major depressive disorder, among which ECT therapy and maintaining them has been researched to evaluate their effectiveness in averting deterioration reoccurrence of depression. This writer further identifies observations by the potential discoveries for ECT response through developing a rat design of pharmacoresistant depression then interpret the findings to a depressive patient in a clinical study.
Design/Method Describe the design and how the study was carried out (In detail, including inclusion/exclusion criteria).	This writer elaborates on the study of the efficacy of Intravenous Ketamine infusion treatment compared with electroconvulsive therapy (ECT). Conduction of the research followed multi-centered, longitudinal, accidental crossover, and other equivalent trials.	This article research method involves a non-randomized longitudinal study where individuals with MDD are evaluated before and after ECT treatment. In this article, healthy controls are compared base on gender and age. Other methods used include magnetic resonance imaging acquired twice and the beginning and following six weeks through a conscious face-matching model.	In the article, the study's inclusions criteria involved randomized controlled exams, individuals older than 18 years with crucial depressive disorder, and response following severe ECT. This article's research method is a comparison between continuous maintenance of ECT for individuals with or without antidepressant therapy and accurate intervention of subsequent ECT continuous single pharmacological antidepressant therapy. Research with ITT analysis was involved in lowering bias in the process of the study.	The study research method to measure depression symptoms on the rats was through the use of a battery behavioral test, and novelty-induced hypophagia to eliminate the bias of getting some effects of CMS. The Wistar rats were chosen in this study since they portray high anxiety-related characteristics, and they respond highly to CMS compared to other rats. In a clinical study from the 11 patients, the response was noted when one reduced >= 50% Montgomery Asberg Depression Scale.
Sample/Setting The number and characteristics of patients, attrition rate, etc.	The study involvedwith 240 participants who were recruited at four centers across Canada. Participants are directly recruited from the ECT services referral and waitlist for each participating hospital.	In this study, there are 37 patients suffering from MDD, and they were treated through ECT, as well as 37 health controls were applied in the current research. The participants were enrolled from the inpatient list from the psychiatry department of the university of muenster. All the patients were suffering from a recent acute depressive experience and achieved the standards of MDD.	The research involved 436 patients who were suffering from a major depressive disorder. All the patients were individuals above the age of 18 years.	This article's research involves 46 male Wistar outbred rats that underwent the CMS protocol. The Wistar outbred rats portray high anxiety behaviors and a high response to CMS compared to other types of rats. The clinical experiment involved 11 in-patients who were experiencing pharmacoresistant depression.
Major Variables Studied List and define dependent and independent variables.	The variable that has been studied here is the comparison between ECT therapies in treating crucial depressive episodes.	The research variable is to study ECT's functional brain effects when emotional processing in major depressive disorder.	This research tries to analyze the efficacy of continuous ECT therapy and maintenance ECT treatment on averting recurrence of depression compared to antidepressant pharmacotherapy.	This study tries to identify if biomarkers' prescreening can assist in recognizing patient eligibility for primary ECT therapy.
Measurement Identify primary statistics used to answer clinical questions (You need to list the actual tests done).	Montgomery-Asberg depression rating scale was used to measure the depression rate among the patients.	ECT was carried out 3 times weekly by the use of Thymatron IV systems, where all the patients were required to have inpatient therapy for the entire period of the ECT series.	This study analyzes the effectiveness of continuous ECT treatment in eliminating the repetitive occurrence of depression compared to antidepressant pharmacotherapy.	The study uses different tests such as the battery of behavioral tests, and novelty-induced hypophagia, among other tests.
Data Analysis Statistical or Qualitative findings (You need to enter the actual numbers determined by the statistical tests or qualitative data).	The main outcome measure is the percentage of participants meeting antidepressant response criteria of less than or equal to 50% reduction in MADRS score of less than 22. The therapeutic impact speed is recognized as the amount of treatment needed for the participant to initially meet antidepressant response standards. The Kaplan-Meier survival analysis is applied to contrast the mean number of needed therapy for initial response to ECT and ketamine in the course of the randomized treatment stage. The side effects are analyzed by adding up the total frequency and seriousness score for the TSEs initiated following the last therapy in the process of randomized treatment.	In this research, the SPSS statistics are used to perform analysis on demographic, clinical, and behavioral data. To analyze ECT's impact on depression seriousness, a t-test was carried out to compare the HDRS rating baseline with the HDRS score following ECT in the MDD category. The evaluation of functional biomarkers involved in ECT response and the responder's pre-treatment brain operation and the non-responder categories was contrasted through a self-sufficient t-test.	The main data analysis used in this study is based on the patients' division into groups of those who experienced a weakening in the process of the study and measured the threat ratio to analyze the distinction between ineffective therapy among the groups. The study information was pooled based on the weighted average, and heterogeneity was assessed using the p values.	The research analysis suggests that when the depression severity was evaluated weekly in the process of ECT treatment. When the Hamilton Depression Scale rating reduced by >= 50% in the process of treatment, it was regarded as a response to therapy.
Findings and Recommendations General findings and recommendations of the research	This article's findings explain that there is a demand to enhance therapy results among people with mood disease, and they do not respond to other treatment methods. Although ECT remains among the most productive intervention for treatment-resistance MDEs, it is still not properly utilized.	The article's findings suggest that ECT is effective since HDRS outcomes were reduced greatly in the MDD category from pre-to post-therapy. The research shows that there is an elevation in ACC processes in individuals suffering from MDD following ECT when processing emotional things of adverse feelings.	The pooled data's research analysis suggested that continuous ECT treatment and maintaining ECT therapy with pharmacotherapy brought about significantly less relapse and recurrence than pharmacotherapy alone.	The CMS depression model is a highly trusted means of reflecting on the symptoms of people's MDD on rats to assess antidepressant therapy effects.
*Appraisal and Study Quality* The worth of the research practice Elaborations of the : Strengths and limitations of the research . Risks associated with the implementation of the suggested practices or processes detailed in the research. Feasibility of use in your practice.	This article's research is objected to compare the effectiveness, speed of therapy effectiveness, the side effects as well as healthcare resources utilization involved in ketamine and ECT through a spontaneous and crossover design with properly communicated clinical results. One of the article's strengths is that it recognizes biomarkers of response to ECT or ketamine, which lowers delay in clinical improvement and improves remission rates. These articles research contributing to explaining the mechanism of the antidepressant impact of ketamine and ECT and recognizing predictors of therapy results.	The research aims at investigating the functional transformation of ECT and biomarkers involved in therapy response when deliberately emotional processing. The results of the article bring out a better comprehension of possible ECT impacts on emotional processing. The strength of this article's research is that it comprises a large number of participants who were receiving ECT therapy and analysis of impact on brain operation corresponds with conscious emotion processing in a future strategy through paradigm-based fMRI.	One of the strengths of this study is its huge number of participants who were receiving ECT treatment. One of the limitations of the research it has limited generalizability due to the age restriction.	One of the limitations of this study is that the researchers did not evaluate methylation or RNA in rats' surrounding circulation, and they also failed to evaluate RNA samples gathered from the patients due to technical issues. The strength of this study is that the researchers were able to access lab rats as well as patients who were suffering from major depressive disorders.
Key findings	Ketamine and ECT are effective strategies to treat blood pressure. With the right monitoring, ketamine may, in the future, be applied as a less inconvenient, possibly more used, and cheaper choice compared to ECT in treatment-resistant individuals who experience MDE.	Following ECT, individuals with MDD showed a remarkable improvement in ACC processes when processing adverse emotional stimuli. This impact has driven some responders, while non-responders showed no increase.	The major finding of the research is that ECT and pharmacotherapy are very effective in reducing the risk of depression from reoccurring.	Patients who respond to ECT should be treated using ECT treatment after the disorder has been recognized, and those patients who do not respond to ECT should not receive ECT treatment since it will lead to increased stigmatization of this treatment option.
Outcomes	With proper checkup, ketamine is less inconvenient, possibly more tolerated, and a cheaper choice compared to ECT in critical depressed treatment resisting individuals who experience MDE.	The study outcome shows that ECT brings about an elevation in ACC activity when processing adverse emotions in patients experiencing critical depressive disorder.	The research outcome shows that continuous ECT is effective in preventing the recurrence of depression compared to antidepressant pharmacotherapy.	The research outcome shows that the promoter methylation does not change with time, but it revealed responders and non-responders since it was higher in responders than in non-responders prior to ECT.
General Notes/Comments	The research can assist in providing understanding and progress in treating MDEs in unipolar MDD and BP.	This study provides a better comprehension of possible ECT impacts on emotional activities when focusing on ACC processes as the biomarker to therapy outcome.	This article's research shows that further study on ECT can be carried out to offer more understanding of its effect on depression.	This study tries to prove that biomarkers' prediction on the response of ECT will reduce costs and recognize patient eligibility for ECT treatment and assist in creating advanced ECT and new treatment methods for the depressed patient who resist presenting antidepressant treatments.